BioRN is a bio-medical research and industry cluster dedicated to the development of the Rhine-Main-Neckar region into one of the world-leading life science cluster. The region counts on a rich startup ecosystem, international public and private investments and attracts top global talent.
Our network association consists of about 100 members.
Our members include:
- about 80 small and medium enterprises (SMEs);
- renowned research institutions such as the University of Heidelberg, the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL), Mannheim University of applied science, University of Kaiserslautern (TU), Karlsruhe Institute of Technology (KIT), Fraunhofer IGB;
- global pharma companies such as AbbVie, Boehringer Ingelheim, Cellzome (a GSK company), Janssen Cilag (a Johnson&Johnson company), Merck, Roche and Sanofi-Aventis;
- local authorities, such as the City of Heidelberg, Mannheim and Ludwigshafen.
Beyond the members registered in the cluster, BioRN gives access to a wider network via partnerships and collaborations.
As a strong network, BioRN promotes cooperation between companies, authorities and universities and works as facilitator between institutions performing basic or applied research, between global healthcare companies and SMEs or start-ups.
Within the scope to strength its visibility and role on national and international level, BioRN recently intensified the collaboration with the Ci3 cluster in Mainz. In terms of the use of clusters for the internationalization of companies, BioRN has founded, together with Leuven (Belgium), Maastricht (Netherlands) and Copenhagen (Denmark), an alliance for the enforcement of biomedical innovation in Europe, called the Health Axis Europe (https://www.health-axis.eu/).